Multi-omics analysis uncovers clinical, immunological, and pharmacogenomic implications of cuproptosis in clear cell renal cell carcinoma

Multi-omics analysis uncovers clinical, immunological, and pharmacogenomic implications of cuproptosis in clear cell renal cell carcinoma

Abstract Objective The latest research proposed a novel copper-dependent programmed cell death named cuproptosis. We aimed to elucidate the influence of cuproptosis in clear cell renal cell carcinoma (ccRCC) from a multi-omic perspective. Methods This study systematically assessed mRNA expression, m...

Full description

Bibliographic Details
Main Authors:	Maoshu Zhu, Yongsheng Li, Yun Wang, Pingli Lin, Jun Mi, Weimin Zhong
Format:	Article
Language:	English
Published:	BMC 2023-07-01
Series:	European Journal of Medical Research
Subjects:	Cuproptosis Clear cell renal cell carcinoma Prognosis Immunogenomics Immunotherapy Precision therapy
Online Access:	https://doi.org/10.1186/s40001-023-01221-4

Similar Items

The core genes of cuproptosis assists in discerning prognostic and immunological traits of clear cell renal cell carcinoma
by: Binxiang Chu, et al.
Published: (2022-09-01)

Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma
by: Gang Luo, et al.
Published: (2023-05-01)

The potential of targeting cuproptosis in the treatment of kidney renal clear cell carcinoma
by: Guojie Lei, et al.
Published: (2023-11-01)

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
by: Lishuo Zhang, et al.
Published: (2023-01-01)

Cuproptosis-Related Genes Are Associated with Cell Cycle and Serve as the Prognostic Signature for Clear Cell Renal Cell Carcinoma
by: Tuanjie Guo, et al.
Published: (2022-12-01)

Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma
by: Ganghua Zhang, et al.
Published: (2022-08-01)

Identification of cuproptosis-related lncRNAs signature for predicting the prognosis in patients with kidney renal clear cell carcinoma
by: Ya He, et al.
Published: (2024-03-01)

Cuproptosis related gene PDHB is identified as a biomarker inversely associated with the progression of clear cell renal cell carcinoma
by: Hu Wang, et al.
Published: (2023-08-01)

The cuproptosis related genes signature predicts the prognosis and correlates with the immune status of clear cell renal cell carcinoma
by: Peng Sun, et al.
Published: (2022-12-01)

Ferredoxin 1, the key regulator of cuproptosis, was associated with prognosis and immune cell infiltration in clear cell renal cell carcinoma
by: Dian Xia, et al.
Published: (2023-03-01)

Cuproptosis in ccRCC: key player in therapeutic and prognostic targets
by: Yang Lv, et al.
Published: (2023-10-01)

Prognostic, Clinicopathological, and Function of Key Cuproptosis Regulator <i>FDX1</i> in Clear Cell Renal Cell Carcinoma
by: Song Zeng, et al.
Published: (2022-09-01)

A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma
by: Wangli Mei, et al.
Published: (2022-08-01)

Tumor microenvironment-based signatures distinguish intratumoral heterogeneity, prognosis, and immunogenomic features of clear cell renal cell carcinoma
by: Aihetaimujiang Anwaier, et al.
Published: (2023-09-01)

Integrated single-cell and bulk characterization of cuproptosis key regulator PDHB and association with tumor microenvironment infiltration in clear cell renal cell carcinoma
by: Jiajin Wu, et al.
Published: (2023-06-01)

Multi-omics analysis reveals prognostic and therapeutic value of cuproptosis-related lncRNAs in oral squamous cell carcinoma
by: Xiaoguang Li, et al.
Published: (2022-08-01)

Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma
by: Junlin Shen, et al.
Published: (2023-02-01)

A novel cuproptosis-related lncRNA prognostic signature for predicting treatment and immune environment of head and neck squamous cell carcinoma
by: Changxiang Huan, et al.
Published: (2022-08-01)

Molecular Subtyping Based on Cuproptosis-Related Genes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell Carcinoma
by: Zhong-Hao Ji, et al.
Published: (2022-07-01)

Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma
by: Bao Wang, et al.
Published: (2022-10-01)

A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
by: Sheng Xin, et al.
Published: (2022-09-01)

Molecular subtypes based on cuproptosis regulators and immune infiltration in kidney renal clear cell carcinoma
by: Aibin Liu, et al.
Published: (2022-10-01)

Cuproptosis: emerging biomarkers and potential therapeutics in cancers
by: Min Wang, et al.
Published: (2023-11-01)

Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma
by: Zhiyong Cai, et al.
Published: (2022-09-01)

Exploration of the role of Cuproptosis genes and their related long non-coding RNA in clear cell renal cell carcinoma: a comprehensive bioinformatics study
by: Dian Xia, et al.
Published: (2022-11-01)

Prognostic value and immunological characteristics of a novel cuproptosis-related long noncoding RNAs risk signature in kidney renal clear cell carcinoma
by: Peng Hong, et al.
Published: (2022-11-01)

CD8+ T Cell-Based Molecular Classification With Heterogeneous Immunogenomic Landscapes and Clinical Significance of Clear Cell Renal Cell Carcinoma
by: Xiangkun Wu, et al.
Published: (2021-12-01)

Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration
by: Yimin Yao, et al.
Published: (2023-01-01)

Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis
by: Xinqiang Li, et al.
Published: (2022-11-01)

Machine learning-driven prognostic analysis of cuproptosis and disulfidptosis-related lncRNAs in clear cell renal cell carcinoma: a step towards precision oncology
by: Ronghui Chen, et al.
Published: (2024-03-01)

Comprehensive analysis of cuproptosis‐related gene expression and positive correlations with CD4+ T cell infiltration in head and neck squamous cell carcinoma
by: Zhangwei Hu, et al.
Published: (2023-09-01)

Maintenance of the human memory T cell repertoire by subset and tissue site
by: Michelle Miron, et al.
Published: (2021-06-01)

Genomic analysis uncovers prognostic and immunogenic characteristics of ferroptosis for clear cell renal cell carcinoma
by: Dan Bai, et al.
Published: (2021-09-01)

Editorial: Cuproptosis and tumor
by: Bing Liu, et al.
Published: (2023-11-01)

Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning
by: Zhixun Bai, et al.
Published: (2022-12-01)

Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma
by: Xiaoling Zhang, et al.
Published: (2023-06-01)

Cuproptosis-related molecular subtypes direct T cell exhaustion phenotypes and therapeutic strategies for patients with lung adenocarcinoma
by: Yi-Pan Zhu, et al.
Published: (2023-04-01)

Characterization of Hypoxia-Related Molecular Subtypes in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy and Targeted Therapy via Multi-Omics Analysis
by: Weimin Zhong, et al.
Published: (2021-06-01)

Comprehensive analysis of cuproptosis in immune response and prognosis of osteosarcoma
by: Mingzhe Li, et al.
Published: (2022-10-01)

Identification and immunological role of cuproptosis in osteoporosis
by: Tongying Chen, et al.
Published: (2024-03-01)